Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic open-angle glaucoma. Review for primary care physicians.

Feisal A Adatia1, Karim F Damji

  • 1Department of Ophthalmology, University of Toronto, Ontario.

Canadian Family Physician Medecin De Famille Canadien
|September 30, 2005
PubMed
Summary

Early detection of chronic open-angle glaucoma (COAG) through timely referrals is crucial for at-risk individuals. Understanding medication side effects is vital for managing glaucoma patients and preventing vision loss.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Systemic and ophthalmic drugs associated with glaucoma: an international, population-based observational study.

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie·2026
Same author

Optometrist-led vision screening: Enhancing child eye health in underserved district schools within Karachi.

SAGE open medicine·2026
Same author

Healthcare Provider Perspectives on the Assessment and Management of Cerebral Visual Impairment in Children.

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques·2026
Same author

Use of retinal ischemic perivascular lesions (RIPLS) as a biomarker for cardiovascular disease - a systematic review and meta-analysis.

International journal of retina and vitreous·2025
Same author

Comparative Analysis of Ocular Adverse Events between Aflibercept 8 mg and Faricimab: A Global Population-Based Study across 65 Countries.

Ophthalmology. Retina·2025
Same author

Association of Anti-VEGF Therapy with Reported Ocular Adverse Events: A Global Pharmacovigilance Analysis.

Ophthalmology. Retina·2025

Area of Science:

  • Ophthalmology
  • Public Health

Background:

  • Chronic open-angle glaucoma (COAG) is a primary cause of irreversible blindness globally, often undetected due to asymptomatic progression.
  • An estimated 50% of COAG cases remain undiagnosed, highlighting a significant public health challenge.

Purpose of the Study:

  • To outline effective casefinding strategies for early detection of chronic open-angle glaucoma.
  • To inform healthcare providers about risk factors and potential adverse effects of glaucoma treatments.

Main Methods:

  • Systematic literature review using MEDLINE.
  • Inclusion of reference lists from relevant articles.
  • Incorporation of expert knowledge from a glaucoma specialist.

Main Results:

Related Experiment Videos

  • Early referral for individuals aged over 50, with a family history of glaucoma, of Black race, or with myopia is recommended.
  • Referral is also supported by moderate evidence for patients with hypertension, type 2 diabetes, hypothyroidism, or sleep apnea.
  • Intraocular pressure-lowering medications can halt disease progression, but topical beta-blockers may cause adverse effects like asthma, cardiovascular issues, depression, and sexual dysfunction.

Conclusions:

  • Optimizing COAG management requires appropriate referral pathways for early detection.
  • Healthcare providers must be aware of common and serious side effects of glaucoma medications to ensure patient safety.